Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease".

Gleason, Adenrele M; Tayebi, Nahid; Lopez, Grisel J; Sidransky, Ellen

Gleason, Adenrele M; Tayebi, Nahid; Lopez, Grisel J; Sidransky, Ellen.

Afiliación

Gleason AM; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Tayebi N; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lopez GJ; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Sidransky E; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Mov Disord ; 37(8): 1781-1782, 2022 08.

Article en En | MEDLINE | ID: mdl-35980034

Asunto(s)

Enfermedad de Parkinson; Biomarcadores; Glucosilceramidasa/genética; Humanos; Mutación; Enfermedad de Parkinson/diagnóstico; Enfermedad de Parkinson/genética; alfa-Sinucleína

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google